Levetiracetam

Synonyms

(S)-2-(2-Oxopyrrolidin-1-yl)butanamide, (S)-α-Ethyl-2-oxo-1-pyrrolidineacetamide, Levetiracetamum, Keppra, Levetiracetam API, Levetiracetam USP, Levetiracetam EP, Levetiracetam BP

Levetiracetam is a widely used antiepileptic drug (AED) that belongs to the racetam class. It is the S-enantiomer of etiracetam and is known for its unique mechanism of action, which involves binding to synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release. This product is a high-purity pharmaceutical intermediate or API, suitable for formulation development and clinical use.

Our Levetiracetam is manufactured under strict quality control, ensuring consistent purity and stability. It is available in various pack sizes to meet research and commercial needs.

Function

• Antiepileptic Agent: Used as an active pharmaceutical ingredient in the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures.
• Neuroprotective Properties: Exhibits potential neuroprotective effects, making it a candidate for research in neurological disorders beyond epilepsy.
• Research Tool: Utilized in pharmacological studies to investigate SV2A binding and synaptic transmission.

Source & Purity

• Source: Synthetic chemical production, not derived from natural sources.
• Standardization: Meets or exceeds USP/EP/BP standards; assay by HPLC ≥ 98%.
• Forms: Available as a crystalline powder; custom particle size options on request.
• Applications: Suitable for oral solid dosage forms (tablets, capsules), oral solutions, and parenteral formulations.

Documentation & Supply

• Monthly capacity: 5,000 kg
• Lead time: 7-10 days for standard orders; custom packaging may require additional time.
• Documentation: COA, MSDS, TDS
• Packaging: Available in 1kg, 5kg, 25kg fiber drums, or as per customer requirement.

Request For Quote

Our Address

280 Main Street, Xian, Shaanxi, China

LyvBio Co., Ltd.
Email: info@lyvbio.com